Top

Published in:

01-07-2014 | Research

Clinicopathologic Significance of Sox2, CD44 and CD44v6 Expression in Intrahepatic Cholangiocarcinoma

Authors: Mi Jin Gu, Byung Ik Jang

Published in: Pathology & Oncology Research | Issue 3/2014

Abstract

Embryonic stem cells (ESC) and cancer stem cells (CSC) have a capacity for self-renewal and differentiation into multiple cell lineages. Sox2 plays a critical role in ESC and has been shown to participate in carcinogenesis and tumor progression in many human cancers. CD44 and CD44v6 are putative CSC markers and their association with tumor progression, metastasis, and tumor relapse after treatment has been demonstrated. We evaluated the immunoexpression of Sox2, CD44, and CD44v6 in 85 cases of Intrahepatic cholangiocarcinomas (IHCC) and assessed their prognostic significance. Sox2 expression showed a significant association with lymph node metastasis (p = 0.025), T4 stage (p = 0.046), and worse overall survival (p = 0.047). Greater expression of Sox2 was observed in IHCC with poor differentiation, vascular invasion, and stage IV, without statistical significance (p > 0.05). CD44 expression showed an association with periductal infiltrative type (p = 0.034), poor differentiation (p = 0.012), and vascular invasion (p = 0.009). CD44v6 expression was evident in patients with stage IV (p = 0.019). These results demonstrated that Sox2 expression is associated with aggressive behavior and poor overall survival in IHCC.

Zhang C, Bai DS, Huang XY et al (2013) Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma. PLoS One 8:e54619PubMedCentralPubMedCrossRef

Ruan J, Wei B, Xu Z et al (2013) Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer. Med Oncol 30:445. doi:10.1007/s12032-012-0445-z PubMedCrossRef

Guo Y, Liu S, Wang P et al (2011) Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology 59:763–775PubMedCrossRef

Ling GQ, Chen DB, Wang BQ et al (2012) Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines. Oncol Lett 4:1264–1268PubMedCentralPubMed

Ben-Porath I, Thomson MW, Carey VJ et al (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40:499–507PubMedCentralPubMedCrossRef

Kitamura H, Torigoe T, Hirohashi Y et al (2013) Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract. Mod Pathol 26:117–124PubMedCrossRef

Brcic L, Sherer CK, Shuai Y et al (2012) Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2. Am J Clin Pathol 138:712–718PubMedCrossRef

Neumann J, Bahr F, Horst D et al (2011) SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 11:518. doi:10.1186/1471-2407-11-518 PubMedCentralPubMedCrossRef

Lengerke C, Fehm T, Kurth R et al (2011) Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 11:42. doi:10.1186/1471-2407-11-42 PubMedCentralPubMedCrossRef

10.

Rodriguez-Pinilla SM, Sarrio D, Moreno-Bueno G et al (2007) Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol 20:474–481PubMedCrossRef

11.

Han X, Fang X, Lou X et al (2012) Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One 7:e41335PubMedCentralPubMedCrossRef

12.

Huang P, Qiu J, Li B et al (2011) Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Clin Biochem 44:582–589PubMedCrossRef

13.

Wilbertz T, Wagner P, Petersen K et al (2011) SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol 24:944–953PubMedCrossRef

14.

Velcheti V, Schalper K, Yao X et al (2013) High SOX2 levels predict better outcome in non-small cell lung carcinomas. PLoS One 8:e61427PubMedCentralPubMedCrossRef

15.

Otsubo T, Akiyama Y, Yanagihara K et al (2008) SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer 98:824–831PubMedCentralPubMedCrossRef

16.

Matsuoka J, Yashiro M, Sakurai K et al (2012) Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res 174:130–135PubMedCrossRef

17.

Nanashima A, Hatachi G, Tsuchiya T et al (2013) Clinical significances of cancer stem cells markers in patients with intrahepatic cholangiocarcinoma who underwent hepatectomy. Anticancer Res 33:2107–2114PubMed

18.

Wakamatsu Y, Sakamoto N, Oo HZ et al (2012) Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int 62:112–119PubMedCrossRef

19.

Palagani V, El Khatib M, Krech T et al (2012) Decrease of CD44-positive cells correlates with tumor response to chemotherapy in patients with gastrointestinal cancer. Anticancer Res 32:1747–1755PubMed

20.

Okayama H, Kumamoto K, Saitou K et al (2009) CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. Oncol Rep 22:745–755PubMed

21.

Klatte T, Seligson DB, Rao JY et al (2010) Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. J Urol 183:2403–2408PubMedCrossRef

22.

Sun C, Sun L, Li Y et al (2013) Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug. Med Oncol 30:503. doi:10.1007/s12032-013-0503-1 PubMedCrossRef

23.

Pongcharoen P, Jinawath A, Tohtong R (2011) Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells. Clin Exp Metastasis 28:827–839PubMedCrossRef

24.

Zlobec I, Gunthert U, Tornillo L, Iezzi G, Baumhoer D, Terracciano L et al (2009) Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer. Histopathology 55:564–575PubMedCrossRef

25.

Avoranta ST, Korkeila EA, Syrjanen KJ et al (2012) Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence. World J Gastroenterol 18:4549–4556PubMedCentralPubMedCrossRef

26.

da Cunha CB, Oliveira C, Wen X et al (2010) De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Investig 90:1604–1614PubMedCrossRef

27.

Afify AM, Tate S, Durbin-Johnson B et al (2011) Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors. Int J Biol Markers 26:50–57PubMedCrossRef

28.

Ashida K, Terada T, Kitamura Y et al (1998) Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology 27:974–982PubMedCrossRef

Title: Clinicopathologic Significance of Sox2, CD44 and CD44v6 Expression in Intrahepatic Cholangiocarcinoma
Authors: Mi Jin Gu
Byung Ik Jang
Publication date: 01-07-2014
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 3/2014
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-014-9745-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Down-regulation of ROBO2 Expression in Prostate Cancers

Fuzzy Clustering Analysis of Osteosarcoma Related Genes

Characterization of the Attenuation of Breast Cancer Bone Metastasis in Mice by Zoledronic Acid Using 99mTc bone Scintigraphy

The Expression of p66Shc Protein in Benign, Premalignant, and Malignant Gastrointestinal Lesions

Association of Genetic Polymorphisms in HSD17B1, HSD17B2 and SHBG Genes with Hepatocellular Carcinoma Risk

Hypoxia-Inducible Factor-1α and its Role in the Proliferation of Retinoblastoma Cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer